The N‐terminal X‐X‐Pro sequence of the HIV‐1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen‐induced proliferation of human T cells
- 1 April 1996
- journal article
- Published by Wiley in FEBS Letters
- Vol. 383 (3) , 145-149
- https://doi.org/10.1016/0014-5793(96)00221-9
Abstract
Recent data in the literature suggest that the HIV‐1 Tat(1–86) protein exhibits immunosuppressive effects. Moreover, Tat was found to interact with dipeptidyl peptidase IV (DP IV), which is identical to the T cell activation marker CD26. Here we show that the N‐terminal amino acid sequence of Tat is essential for the inhibition of DP IV‐catalyzed IL‐2(1–12) degradation. N‐terminal modification of Tat with rhodamine prevented inhibition of enzymatic activity of DP IV as well as suppression of DNA synthesis of mitogen‐stimulated human T cells. Moreover, natural peptides containing the X‐X‐Pro N‐terminal motif of Tat also inhibited DP IV activity. These data suggest the existence of endogenous immunomodulatory oligopeptides which influence immune cell proliferation and differentiation via DP IV as does HIV‐1 Tat.Keywords
This publication has 20 references indexed in Scilit:
- Functional role of CD26 on human B lymphocytesImmunology Letters, 1995
- Inhibitors of Dipeptidyl Peptidase IV (DP IV, CD26) Specifically Suppress Proliferation and Modulate Cytokine Production of Strongly CD26 Expressing U937 CellsImmunobiology, 1994
- CD26: a surface protease involved in T-cell activationImmunology Today, 1994
- Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patientsNature, 1990
- Inhibition of Antigen-Induced Lymphocyte Proliferation by Tat Protein from HIV-1Science, 1989
- Dipeptidyl Peptidase IV in Human T LymphocytesScandinavian Journal of Immunology, 1989
- The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitroEuropean Journal of Immunology, 1986
- The trans-activator gene of the human T cell lymphotropic virus type III is required for replicationCell, 1986
- Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Trans -Acting Transcriptional Regulation of Human T-Cell Leukemia Virus Type III Long Terminal RepeatScience, 1985